Search results
Results from the WOW.Com Content Network
CPS is also available online by subscription at www.pharmacists.ca. Most of the drug monographs in CPS are provided by manufacturers, though numerous monographs—usually for drugs which are available as generic brands— are written by CPhA editorial staff and peer reviewed. 2010 marked the 50th anniversary of the first edition of CPS.
Invisible disabilities, also known as hidden disabilities or non-visible disabilities (NVDs), are disabilities that are not immediately apparent. They are typically chronic illnesses and conditions that significantly impair normal activities of daily living .
Other non-FDA-approved uses for prazosin include the treatment of Raynaud's disease and poisoning due to scorpion venom. Propranolol (Inderal) for performance anxiety: propranolol is a non-selective beta-blocker used for the treatment of hypertension and the prophylaxis of angina pectoris. In 1991, a published study showed that a single dose of ...
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
This list covers alternative therapies for developmental and learning disabilities. None of these therapies are supported by scientific evidence. None of these therapies are supported by scientific evidence.
The Food and Drug Administration on Friday cleared the way for Florida's first-in-the-nation plan to import prescription drugs from Canada, a long-sought approach to accessing cheaper medications ...
[1] [5] In 2006, the organization became the Canadian Agency for Drugs and Technologies in Health (CADTH). [ 3 ] [ 6 ] The limited scope of the CADTH, which was primarily concerned with technical expertise, proved ineffective at handling issues of inadequate infrastructure, poor return on investment, duplication of resources, and above all ...
The Controlled Drugs and Substances Act (French: Loi réglementant certaines drogues et autres substances) is Canada's federal drug control statute. Passed in 1996 under Prime Minister Jean Chrétien's government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drugs Act, and establishes eight Schedules of controlled substances and two Classes of precursors.